figshare
Browse
12948_2021_146_MOESM1_ESM.docx (14.28 kB)

Additional file 1 of Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis

Download (14.28 kB)
journal contribution
posted on 2021-05-22, 03:36 authored by Giorgio Walter Canonica, Francesco Blasi, Nunzio Crimi, Pierluigi Paggiaro, Alberto Papi, Francesca Fanelli, Annalisa Stassaldi, Gianluca Furneri
Additional file1 :Table S3. Codes considered for patient inclusion in the Veneto study [41].

Funding

Sanofi SpA (IT)

History

Usage metrics

    Clinical and Molecular Allergy

    Categories

    Keywords

    Type 2 asthmaDupilumabBiomarkersItaly

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC